Enhanced Antitumor Efficacy of Oncolytic Adenovirus-Loaded Menstrual Blood-Derived Mesenchymal Stem Cells in Combination With Peripheral Blood Mononuclear Cells.
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0431
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2018
Authors
Publisher
American Association for Cancer Research (AACR)